Greenhaven Associates’s NOV NOV Stock Holding History
Bought
Maintained
Sold
Other funds holding NOV
OP
FAMI
Greenhaven Associates's NOV Position: Q2 2026 in Review
Greenhaven Associates reduced its NOV (NOV) stake by 2.3% in Q2 2026, selling an estimated $2.62M and leaving 5,620,019 shares worth $104M. The position accounts for 1.2% of the portfolio, ranked #18.
Greenhaven Associates first reported a position in NOV in Q3 2023 and has held it in 12 quarters since. The position peaked at $108M in Q1 2026. 197 funds tracked by Wall St. Rank hold NOV as of Q2 2026.
- Greenhaven Associates held 5,620,019 shares of NOV worth $104M as of Q2 2026.
- Greenhaven Associates sold 131,319 NOV shares in Q2 2026, an estimated $2.62M.
- NOV made up 1.2% of Greenhaven Associates's portfolio in Q2 2026, its #18 holding.
- Greenhaven Associates first reported a position in NOV in Q3 2023 and has held it in 12 quarters since.
- Greenhaven Associates's NOV position peaked at $108M in Q1 2026.
- 197 funds tracked by Wall St. Rank held NOV as of Q2 2026.
Based on Greenhaven Associates's 13F filing for Q2 2026, filed 28 Jul 2026.